Maiti, A. et al. 2025. The BRIDGE-DS Study: Improved Glycemic Control and Renal Function in Type 2 Diabetes Mellitus Patients Using the Fixed-Dose Combination of Dapagliflozin and Sitagliptin. Journal of Endocrinology & Metabolism. 15, 4 (Oct. 2025), 153–160. DOI:https://doi.org/10.14740/jem1055.